<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1344">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05143658</url>
  </required_header>
  <id_info>
    <org_study_id>KanuniSSS</org_study_id>
    <nct_id>NCT05143658</nct_id>
  </id_info>
  <brief_title>Comparison of Laparoscopic Pectopexy and Laparoscopic Lateral Suspension Techniques in Uterine-preserving Apical Prolapsus Repair</brief_title>
  <official_title>Comparison of Laparoscopic Pectopexy and Laparoscopic Lateral Suspension Techniques in Uterine-preserving Apical Prolapsus Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanuni Sultan Suleyman Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study will be to compare the laparoscopic pectopexy (LP) and laparoscopic&#xD;
      lateral suspension (LLS) techniques in the management of uterine sparing apical prolapse&#xD;
      (POP-Q &gt;2) at 1 year and yearly up to 2 years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary and secondary endpoints:&#xD;
&#xD;
      Primary outcome measures will be the subjective cure of prolapse (&quot;absence or presence of a&#xD;
      bulge in the vagina&quot;), objective success with anatomic absence of advanced prolapse at POP-Q&#xD;
      sites Ba, C and Bp defined as less than 1 cm individually and as a total.&#xD;
&#xD;
      Secondary outcome measures include all other parameters such as perioperative outcomes,&#xD;
      patient satisfaction, quality of life outcomes, complications, scores on questionnaires, and&#xD;
      reoperations.&#xD;
&#xD;
      The study protocol will be submitted to the institutional review boards of every&#xD;
      participating study site and written informed consent will be obtained from all participants&#xD;
      on enrolment.&#xD;
&#xD;
      Project design: The investigators will perform an international multicentre single-blind&#xD;
      randomized controlled trial with participating our tertiary referral hospital.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 22, 2021</start_date>
  <completion_date type="Anticipated">November 22, 2024</completion_date>
  <primary_completion_date type="Actual">November 22, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective cure rate of prolapse</measure>
    <time_frame>[ Time Frame: 12 months after intervention ]</time_frame>
    <description>Provided by the patient's feeling of the &quot;Absence of a bulge in the vagina&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Objective success</measure>
    <time_frame>[ Time Frame: 12 months after intervention ]</time_frame>
    <description>Defined as anatomic absence of advanced prolapse at POP-Q sites Ba, C and Bp defined as less than 1 cm individually and as a total</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prolapse-related Quality of life</measure>
    <time_frame>[ Time Frame: 12 months after intervention ]</time_frame>
    <description>This will be assessed using a validated questionnaire (Prolapse Quality of Life questionnaire P-QoL) The questionnaire contains 9 domains. Each answer of the patient will have values that range between 1 to 4 or 1 to 5 for the 1st question only). (1 very good 4/5 very poor). There is no overall score. A symptomatic woman might have only one domain impaired and another one might have all domains impaired. We consider both of them symptomatic but in different or same aspects of quality of life. To differentiate different domains, it is important for the decision of our surgery (we will be careful in shortening and narrowing a vagina of a woman who had only a preoperative high (impaired) Personal relationships domain score and other domains in the normal range).&#xD;
This will also help us in the follow up visits.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Failure (%)</measure>
    <time_frame>[ Time Frame: 12 months after intervention ]</time_frame>
    <description>Recurrence rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>[ Time Frame: 12 months after intervention ]</time_frame>
    <description>İnjury ( bowel, intestinal, blood vessel injuries, mesh erosions)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)</measure>
    <time_frame>[ Time Frame: 12 months after intervention ]</time_frame>
    <description>The PISQ-12 is a self-adminestered questionnaire that evaluates sexual function of women with pelvic organ prolapse or urinary incontinence. The questionnaire has 12 items. Other than the first 4 questions that are scored from 4 to 0, all questions are scored from 0 to 4. The total score is calculated with totaling the score of each question. The maximum score is 48. Higher scores show good sexual functioning of women.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incontinence Impact Questionnaire (IIQ-7)</measure>
    <time_frame>[ Time Frame: 12 months after intervention ]</time_frame>
    <description>evaluating the impact of urinary incontinence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Floor Distress Inventory (PFDI - 20)</measure>
    <time_frame>[ Time Frame: 12 months after intervention ]</time_frame>
    <description>evaluating the bowel, bladder, or pelvic symptoms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Laparoscopic Lateral Suspension Group (LLS)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anterior and apical prolapse repair via LLS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic Pectopexy (LP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anterior and apical prolapse repair via LP</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LLS versus LP</intervention_name>
    <description>Procedure: Laparoscopic repair of anterior and apical pelvic organ prolapse Surgical correction of anterior and apical pelvic organ prolapse by laparoscopy</description>
    <arm_group_label>Laparoscopic Lateral Suspension Group (LLS)</arm_group_label>
    <arm_group_label>Laparoscopic Pectopexy (LP)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women with symptomatic stage 2 or greater (point C -1 or more pelvic organ prolapse&#xD;
             quantification POP-Q) apical prolapse&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women not eligible for surgery for medical or anesthesiological reasons&#xD;
&#xD;
          -  Inability to comprehend questionnaires&#xD;
&#xD;
          -  Inability to give informed consent&#xD;
&#xD;
          -  Inability to return for a review&#xD;
&#xD;
          -  Prior laparoscopic prolapse repair&#xD;
&#xD;
          -  Prior vaginal mesh prolapse procedure&#xD;
&#xD;
          -  Severe cardiovascular or respiratory disease&#xD;
&#xD;
          -  Women who don't want uterine preserving surgery&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Age &lt;18 years, Age &gt;45 years&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ozan Karadeniz, MD</last_name>
    <phone>+905333663003</phone>
    <email>dr.ozankrdnz@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ömer Ünal, MD</last_name>
    <phone>+905533888766</phone>
    <email>dr.omer-unal@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kanuni Sultan Suleyman Training and Research Hospital</name>
      <address>
        <city>İstanbul</city>
        <zip>34307</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 28, 2021</study_first_submitted>
  <study_first_submitted_qc>November 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2021</study_first_posted>
  <last_update_submitted>November 22, 2021</last_update_submitted>
  <last_update_submitted_qc>November 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kanuni Sultan Suleyman Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Ozan Karadeniz</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>pectopexy</keyword>
  <keyword>lateral suspension</keyword>
  <keyword>pelvic organ prolapse</keyword>
  <keyword>uterine sparing</keyword>
  <keyword>laparoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

